Introduction: The Aequs IPO Opportunity
The Aequs Limited IPO opens for subscription from December 3 to December 5, 2025, marking a critical juncture for this precision engineering specialist. With a price band set at ₹118 to ₹124 per share and an issue size of ₹921.81 crore, this public offering represents more than just capital raising—it’s a potential turnaround story for a company with a strong aerospace foundation burdened by financial challenges. As India positions itself as a global manufacturing hub under the “Make in India” initiative, Aequs stands at the intersection of strategic opportunity and operational risk, making this one of the more complex IPOs to evaluate in recent times.
Business Model: Vertical Integration in Aerospace
Aequs operates a vertically integrated “one-stop shop” manufacturing model that distinguishes it from many competitors. Approximately 88% of its revenue derives from the aerospace sector, where it produces precision components, assemblies, and sub-systems for industry giants including Airbus and Boeing. The company’s operations are concentrated within a specialized Special Economic Zone (SEZ) cluster in Karnataka, designed to provide seamless manufacturing from forging and machining to sheet metal fabrication and sub-assembly under one roof.
This integrated approach offers significant advantages to global original equipment manufacturers (OEMs) seeking to streamline their supply chains. By reducing logistics complexity and improving coordination, Aequs delivers time and cost savings that have helped secure long-standing customer relationships averaging 11 years. Beyond aerospace, the company maintains a smaller consumer vertical manufacturing components for electronics and cookware, though this segment has consistently generated losses, weighing on overall profitability.
Financial Health: A Story of Losses and Recent Improvement
Aequs presents a financial picture of a company in transition. For the last three consecutive fiscal years (FY23-FY25), the company has reported net losses, with the most recent FY25 loss standing at ₹102.35 crore on revenues of ₹959 crore. This pattern of unprofitability raises legitimate concerns about the company’s operational efficiency and business model sustainability.
However, more recent data reveals encouraging signs of improvement. For the first half of FY26 (ending September 2025), the net loss has narrowed substantially to ₹16.98 crore, compared to ₹71.70 crore during the same period the previous year. This suggests management’s restructuring efforts may be gaining traction. The company’s consolidated borrowings stood at ₹533.51 crore as of September 2025, representing a significant financial burden that the IPO aims to address directly.
IPO Objectives: Where Will the Money Go?
Understanding the allocation of IPO proceeds is crucial for evaluating the offering’s potential impact. The ₹921.81 crore issue comprises two components with distinctly different purposes:
Fresh Issue (₹670 crore): This capital injection into the company will be deployed as follows:
- Debt Repayment (₹453.4 crore): The largest portion will retire existing borrowings, reducing interest costs and strengthening the balance sheet
- Capital Expenditure (₹80.6 crore): Funding for new machinery primarily to enhance aerospace manufacturing capabilities
- Inorganic Growth & General Corporate Purposes: The remaining balance for strategic initiatives
Offer for Sale (₹251.81 crore): This component involves existing shareholders—primarily private equity funds and promoter entities—divesting a portion of their holdings. These funds flow directly to selling shareholders rather than into company coffers.
Valuation Assessment: Pricey for a Loss-Making Firm?
Valuing a company without consistent profits presents unique challenges. Since traditional Price-to-Earnings (P/E) ratios cannot be applied, analysts typically examine Price-to-Sales (P/S) multiples for comparison. Based on the post-IPO equity and FY25 revenue, Aequs commands a P/S multiple of approximately 9x.
This valuation appears conservative compared to profitable precision engineering peers like Azad Engineering (P/S of 23.7x) and Unimech Aerospace (P/S of 20.4x), but reflects the company’s current unprofitability. The Grey Market Premium (GMP) of approximately ₹46.5 suggests strong secondary market interest, potentially indicating a 37.5% listing gain, though GMP remains an unofficial and volatile indicator that should not form the sole basis for investment decisions.
Strengths: The Bull Case for Aequs
Strategic Aerospace Positioning: As global aerospace companies diversify their supply chains away from traditional hubs, Aequs’s established presence positions it as a beneficiary of this geopolitical shift. Its vertically integrated SEZ campus provides a competitive edge in attracting manufacturers seeking simplified logistics.
Proven Customer Relationships: With an average 11-year relationship with major aerospace clients, Aequs demonstrates its ability to meet stringent quality and delivery standards in a highly regulated industry. This track record provides revenue visibility that many manufacturing businesses lack.
Significant Growth Capacity: Currently operating at approximately 42% capacity utilization, the company possesses substantial headroom to increase revenues without immediate major capital investment. This operational leverage could translate rapidly to improved profitability as volumes increase.
Export-Led SEZ Benefits: Generating over 88% of revenue from exports while operating within an SEZ provides substantial duty and tax advantages that support competitive pricing in international markets.
Risks: The Challenges Ahead
Persistent Profitability Concerns: Despite recent improvement, the three-year history of net losses and negative Return on Equity (ROE) cannot be ignored. The struggling consumer vertical continues to drag on overall performance, raising questions about whether management should divest this segment entirely.
Elevated Financial Leverage: Even after the proposed debt repayment, the company maintains a leveraged balance sheet. Approximately 40% of remaining debt is denominated in unhedged foreign currency, creating exposure to exchange rate volatility that could significantly impact repayment costs.
Problematic Working Capital Cycle: The company’s cash conversion cycle stretched to 253 days in FY25, a concerning increase from 157 days in FY23. This means it takes over eight months to convert inventory investments into cash, straining liquidity and requiring continued borrowing to fund operations.
Customer Concentration Risk: Over 82% of revenue originates from just ten customer groups. While these are blue-chip aerospace companies, this concentration creates vulnerability to order reductions from any single major client.
Expert Perspectives: Mixed Views Reflect Complexity
Financial analysts remain divided on the Aequs IPO, reflecting its nuanced risk-reward profile:
Cautious Approach Recommended: Some analysts, those from the ET Intelligence Group, suggest investors may want to wait for clearer evidence of sustained financial improvement post-listing. They note the company’s EBITDA margins trail profitable peers, and years of losses warrant a more conservative “wait-and-see” approach.
High-Risk Opportunity Acknowledged: Other market observers conclude the IPO is suitable only for investors with high risk tolerance and a long-term horizon. They acknowledge the current financial weaknesses but see potential in the strategic aerospace business, post-IPO deleveraging, and alignment with India’s manufacturing growth story.
Final Verdict: Who Should Consider This IPO?
The Aequs IPO represents a strategic bet on India’s aerospace manufacturing ascent rather than an investment in current financial strength. The offering’s success hinges entirely on management’s ability to execute a clear turnaround plan: achieving sustainable profitability, improving working capital efficiency, and leveraging unused capacity in the core aerospace business.
This offering is not appropriate for: Conservative investors, those seeking steady dividends, or anyone with low risk tolerance. The history of losses and operational challenges makes this a volatile proposition in the short to medium term.
This IPO may merit consideration for: Investors with high risk tolerance, a long-term perspective (3-5 years minimum), and confidence in India’s aerospace manufacturing trajectory. Those who believe management can replicate its recent half-year improvement consistently may find the current valuation reasonable for the potential upside.
As with any IPO, prospective investors should carefully review the Red Herring Prospectus (RHP), assess how Aequs fits within their broader portfolio strategy, and consider consulting with a financial advisor to align this decision with their specific investment goals and risk profile.
Disclaimer: This analysis is for informational purposes only and does not constitute financial advice. Investors should conduct their own due diligence or consult with a qualified financial advisor before making investment decisions. IPO investments carry inherent risks including potential loss of principal. Past performance does not guarantee future results.
